News
Press release
23/01/2024
Oncodesign Services Acquires ZoBio
Acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery, by Oncodesign Services.
News
05/12/2023
Oncolytic Virus Research
Oncodesign Services has been working with ViraTherapeutics GmbH, an Austrian company and subsidiary of Boehringer Ingelheim, on their oncolytic viral immunotherapy since 2018.
News
31/10/2023
Navigating from molecules to medicines in our chemistry department
Christophe Parsy, Ph.D, MBA, head of the medicinal chemistry team since 2020, presents his team's daily challenges and missions.
News
19/10/2023
Breast cancer awareness month
To progress through new treatments, Oncodesign Services supports since many years pharmaceutical companies with breast cancer models such as PDX and CDX models.
Congress
02/10/2023
EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oncodesign Services will be attending to EORTC 2023 ! Fix a meeting now.
27/09/2023
Meet Marie!
Every day, as an invivo research technician, Marie participates in the in vivo studies and tests the effects of a new molecule or a new product. Discover her journey and learn more about working in a lab as a technician.
News
05/07/2023
Oncodesign Services receives global excellence awards
Oncodesign Services is thrilled to announce that we have been awarded 'Best Preclinical Services & Drug Discovery Company 2023 – France!
Press release
27/06/2023
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET technology
Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc.
News
22/05/2023
Oncodesign Services and Veritas In Silico enter into business cooperation
Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.
News
10/05/2023
Dr Eftychia Koumarianou joins as head of pharmaco-imaging and molecular radiotherapy
We announce the appointment of Dr Eftychia Koumarianou as head of its pharmaco-imaging and molecular radiotherapy (MRT) department.
Blog
12/04/2023
Challenges and perspectives in the preclinical development of therapeutic agents against lung fibrosis
In this blog, Pauline Bornert examines the current knowledge about pulmonary fibrosis, and preclinical options available to develop new therapeutic solutions.
Congress
14/03/2023
AACR Annual Meeting 2023
The AACR Annual Meeting brings together scientists, clinicians, and other professionals to share the latest advances in cancer science. Learn more here